Everolimus eluting stent vs first generation drug-eluting stent in primary angioplasty: A pooled patient-level meta-analysis of randomized trials

被引:53
作者
De Luca, Giuseppe [1 ]
Smits, Peter [2 ]
Hofma, Sjoerd H. [3 ]
Di Lorenzo, Emilio [4 ]
Vlachojannis, Georgios J. [2 ]
van't Hof, Arnoud W. J. [5 ]
van Boven, Ad J. [3 ]
Kedhi, Elvin [5 ]
Stone, Gregg W. [6 ]
Suryapranata, Harry [7 ]
机构
[1] Eastern Piedmont Univ, Div Cardiol, Osped Maggiore della Carita, Novara, Italy
[2] Maasstad Hosp, Div Cardiol, Rotterdam, Netherlands
[3] Leeuwarden Med Ctr, Div Cardiol, Leeuwarden, Netherlands
[4] SG Moscati, Div Cardiol, Avellino, Italy
[5] ISALA, Div Cardiol, Zwolle, Netherlands
[6] Columbia Univ, Med Ctr, Cardiovasc Res Fdn, New York, NY USA
[7] Radboud Univ Nijmegen Med Ctr, Dept Cardiol, Nijmegen, Netherlands
关键词
ELEVATION MYOCARDIAL-INFARCTION; BARE-METAL STENTS; PERCUTANEOUS CORONARY INTERVENTION; PATIENTS RISK PROFILE; 5-YEAR FOLLOW-UP; BIODEGRADABLE POLYMER; CLINICAL-IMPLICATIONS; BALLOON ANGIOPLASTY; REGRESSION ANALYSIS; REVASCULARIZATION;
D O I
10.1016/j.ijcard.2017.06.022
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Several concerns have emerged about the higher risk of very late stent thrombosis (ST) with first generation drug-eluting stent (DES) especially among STEMI patients. Newer generation DES has demonstrated to reduce ST at mid-term follow-up. Therefore, the aim of the present study is to performan individual patient's data meta-analysis of trials comparing 1st generation DES vs. 2nd generation DES (everolimus-eluting stent, EES) in patients undergoing primary percutaneous coronary intervention (PCI) for STEMI. Methods: We performed a formal search of electronic databases (MEDLINE and CENTRAL) and scientific session presentations from January 2010 to June 2016. We included all completed randomized trials comparing 1st vs. EES for patient presenting with STEMI. Results: Individual patients data were obtained from 3 trials, including a total of 1581 patients (686 or 43.4% randomized to 1st generation DES and 895 or 56.4% randomized to EES). At long-term follow-up (1584 +/- 588 days), EES did not significantly reduce mortality (7.8.% vs 11.7%, HR [95% CI]= 0.77 [0.52, 1.13], p= 0.18, p(heterogeneity) = 0.93), cardiac mortality (6.2% vs 7.6%, HR [95% CI] = 0.90 [0.56, 1.44], p = 0.65, p(heterogeneity) = 0.85), and reinfarction (8.1% versus 11.2%, respectively; HR [95% CI] = 0.74 [0.51, 1.07], p = 0.11, p(heterogeneity) = 0.52). However, EES significantly reduced the occurrence of ST (3.4% versus 6.1% respectively, HR [95% CI] = 0.56 [0.32, 0.97], p = 0.04, p(heterogeneity) = 0.42) and target vessel revascularization (TVR) (14.2% versus 20.1%; HR [95% CI]= 0.63 [0.42, 0.96], p = 0.03, p(heterogeneity) = 0.55). Landmark analysis showed more consistent benefits in ST with EES within 1 year, whereas benefits in TVR were mostly observed later than 1 year. Conclusions: The present pooled patient-levelmeta-analysis demonstrates that among STEMI patients undergoing primary PCI, EES as compared to 1st generationDES is associatedwith a significant reduction in ST and TVR at long-term follow-up. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:121 / 127
页数:7
相关论文
共 50 条
[41]   Safety and efficacy of ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer drug-eluting stents: a meta-analysis of randomized trials [J].
Ping Zhu ;
Xin Zhou ;
Chenliang Zhang ;
Huakang Li ;
Zhihui Zhang ;
Zhiyuan Song .
BMC Cardiovascular Disorders, 18
[42]   Intravascular ultrasound-guided vs angiography-guided drug-eluting stent implantation in complex coronary lesions: Meta-analysis of randomized trials [J].
Bavishi, Chirag ;
Sardar, Partha ;
Chatterjee, Saurav ;
Khan, Abdur Rahman ;
Shah, Arpit ;
Ather, Sameer ;
Lemos, Pedro A. ;
Moreno, Pedro ;
Stone, Gregg W. .
AMERICAN HEART JOURNAL, 2017, 185 :26-34
[43]   Stent thrombosis in early-generation drug-eluting stents versus newer-generation everolimus-eluting stent assorted by LVEF [J].
van Boven, Nick ;
Windecker, Stephan ;
Umans, Victor A. ;
van Domburg, Ron T. ;
Kardys, Isabella ;
Akkerhuis, K. Martijn ;
van Geuns, Robbert-Jan ;
Serruys, Patrick W. ;
Magro, Michael ;
Raeber, Lorenz ;
Boersma, Eric .
HEART, 2015, 101 (01) :50-57
[44]   Drug-eluting stents in acute myocardial infarction: updated meta-analysis of randomized trials [J].
Dibra, Alban ;
Tiroch, Klaus ;
Schulz, Stefanie ;
Kelbaek, Henning ;
Spaulding, Christian ;
Laarman, Gerrit J. ;
Valgimigli, Marco ;
Di Lorenzo, Emilio ;
Kaiser, Christoph ;
Tierala, Ilkka ;
Mehilli, Julinda ;
Campo, Gianluca ;
Thuesen, Leif ;
Vink, Maarten A. ;
Schalij, Martin J. ;
Violini, Roberto ;
Schoemig, Albert ;
Kastrati, Adnan .
CLINICAL RESEARCH IN CARDIOLOGY, 2010, 99 (06) :345-357
[45]   Outcomes With Intravascular Ultrasound-Guided Stent Implantation A Meta-Analysis of Randomized Trials in the Era of Drug-Eluting Stents [J].
Elgendy, Islam Y. ;
Mahmoud, Ahmed N. ;
Elgendy, Akram Y. ;
Bavry, Anthony A. .
CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (04)
[46]   Stent Thrombosis With Drug-Eluting Stents and Bioresorbable Scaffolds Evidence From a Network Meta-Analysis of 147 Trials [J].
Kang, Si-Hyuck ;
Chae, In-Ho ;
Park, Jin-Joo ;
Lee, Hak Seung ;
Kang, Do-Yoon ;
Hwang, Seung-Sik ;
Youn, Tae-Jin ;
Kim, Hyo-Soo .
JACC-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (12) :1203-1212
[47]   Second-generation versus first-generation drug-eluting stents in saphenous vein graftdisease: A meta-analysis of randomized controlled trials [J].
Shi, Hong-tao ;
Chu, Hong-xia ;
Gu, Wei ;
Cai, Xin-yong ;
Guo, Jun-jie ;
Ding, Zhao-gang ;
Gao, Wei ;
Ma, Lei-lei ;
Zhu, Jian-bing ;
Liu, Hai-bo ;
Huang, Zhe-yong ;
Wang, Qi-bing ;
Ge, Jun-bo ;
Wen, Shao-jun .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 214 :394-398
[48]   Effect of Increasing Stent Length on 3-Year Clinical Outcomes in Women Undergoing Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents Patient-Level Pooled Analysis of Randomized Trials From the WIN-DES Initiative [J].
Chandrasekhar, Jaya ;
Baber, Usman ;
Sartori, Samantha ;
Stefanini, Giulio G. ;
Sarin, Michele ;
Vogel, Birgit ;
Farhan, Serdar ;
Camenzind, Edoardo ;
Leon, Martin B. ;
Stone, Gregg W. ;
Serruys, Patrick W. ;
Wijns, William ;
Steg, Philippe G. ;
Weisz, Giora ;
Chieffo, Alaide ;
Kastrati, Adnan ;
Windecker, Stephan ;
Morice, Marie-Claude ;
Smits, Pieter C. ;
von Birgelen, Clemens ;
Mikhail, Ghada W. ;
Itchhaporia, Dipti ;
Mehta, Laxmi ;
Kim, Hyo-Soo ;
Valgimigli, Marco ;
Jeger, Raban V. ;
Kimura, Takeshi ;
Galatius, Soren ;
Kandzari, David ;
Dangas, George ;
Mehran, Roxana .
JACC-CARDIOVASCULAR INTERVENTIONS, 2018, 11 (01) :53-65
[49]   Stent Thrombosis with Biodegradable Polymer Drug-Eluting Stents versus Durable Polymer Sirolimus-Eluting Stents: An Update Meta-Analysis [J].
Zhu, Lin ;
Lv, Yi Ning ;
Wang, Li Yu .
CARDIOLOGY, 2015, 130 (02) :96-105
[50]   Safety and Efficacy of New-Generation Drug-Eluting Stents in Women at High Risk for Atherothrombosis From the Women in Innovation and Drug-Eluting Stents Collaborative Patient-Level Pooled Analysis [J].
Giustino, Gennaro ;
Baber, Usman ;
Salianski, Olga ;
Sartori, Samantha ;
Stone, Gregg W. ;
Leon, Martin B. ;
Aquino, Melissa ;
Stefanini, Giulio G. ;
Steg, P. Gabriel ;
Windecker, Stephan ;
O' Donoghue, Monica ;
Wijns, William ;
Serruys, Patrick W. ;
Valgimigli, Marco ;
Morice, Marie-Claude ;
Camenzind, Edoardo ;
Weisz, Giora ;
Smits, Pieter C. ;
Kandzari, David ;
Von Birgelen, Clemens ;
Dangas, George D. ;
Cha, Jin Y. ;
Galatius, Soren ;
Jeger, Raban V. ;
Kimura, Takeshi ;
Mikhail, Ghada W. ;
Itchhaporia, Dipti ;
Mehta, Laxmi ;
Ortega, Rebecca ;
Kim, Hyo-Soo ;
Kastrati, Adnan ;
Genereux, Philippe ;
Chieffo, Alaide ;
Mehran, Roxana .
CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (01)